NCT03146507

Brief Summary

The fetal heart plays a central role in the adaptive mechanisms for hypoxemia and placental insufficiency. Longitudinal data on the hemodynamic sequence of the natural history of fetal growth restriction show that the umbilical artery and middle cerebral artery are the first variables to become abnormal . These arterial Doppler abnormalities are followed by abnormalities in the right cardiac diastolic indices, followed by the right cardiac systolic indices, and finally by both left diastolic and systolic cardiac indices . Preserving the left systolic function as the last variable to become abnormal ensures an adequate left ventricular output , which supplies the cerebral and coronary circulations.This defence is contingent on the fetal cardiovascular system, which in late gestation adopts strategies to decrease oxygen consumption and redistribute the cardiac output away from peripheral vascular beds and towards essential circulations, such as those perfusing the brain. Adding cardiac Doppler may improve management of the IUGR fetus(intrauterine growth retardation), Doppler ultrasound is valuable in defining the degree of cardiovascular compromise in at-risk pregnancies. The severity of fetal blood flow redistribution shows the degree of fetal adaptation and provides information on how long the pregnancy can be continued safely. The aime of the study is assessment of cardiac output redistribution in fetal hypoxia by estimating relative right to left side cardiac output wich reflect cardiac sparing in (IUGR).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

4.8 years

First QC Date

May 7, 2017

Last Update Submit

November 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The relative cardiac output ratio (ratio between right side cardiac outputs to left side) cardiac output) at 32-34 weeks.

    1 month

Secondary Outcomes (6)

  • The relative cardiac output ratio at 34-36 weeks.

    1 month

  • The pulsatility index in the umbilical artery and middle cerebral artery at 32-34 weeks

    1 month

  • The pulsatility index in the umbilical artery and middle cerebral artery at 34-36 weeks

    1 month

  • Middle cerebral artery pulsatility index to umbilical artery pulsatility index ratio

    15 minutes

  • Time of delivery (weeks)

    7 weeks

  • +1 more secondary outcomes

Study Arms (2)

Normal pregnant women at 32-34 weeks group

OTHER
Radiation: UltrasoundRadiation: Doppler ultrasoundRadiation: Fetal echocardiography

Intrauterine growth restriction at 32-34 weeks group

OTHER
Radiation: UltrasoundRadiation: Doppler ultrasoundRadiation: Fetal echocardiography

Interventions

UltrasoundRADIATION

ultrasound assessment of gestational age, amniotic fluid index, and fetal weight

Intrauterine growth restriction at 32-34 weeks groupNormal pregnant women at 32-34 weeks group

Umbilical artery and Middle cerebral artery Doppler blood flow assesment

Intrauterine growth restriction at 32-34 weeks groupNormal pregnant women at 32-34 weeks group

The cardiac output (ratio between right side cardiac outputs to left side cardiac output) was calculated

Intrauterine growth restriction at 32-34 weeks groupNormal pregnant women at 32-34 weeks group

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 20-35 years.
  • Women with BMI from 20-30 kg/m2.
  • Pregnant women in singleton fetuses from 32 to 34 weeks gestation.
  • Women with late fetal growth restriction fetuses. It refers to an estimated fetal weight or abdominal circumference \<10th centile. Those women had increased the resistant index (RI) in umbilical arteries above the 95th percentile at the time of recruitment (case group).
  • Normal pregnant women (control group).

You may not qualify if:

  • Women with estimated fetal weight below the 5th or 3rd percentile.
  • Women with premature pre-labor rupture of membranes.
  • Women with antepartum hemorrhage
  • Women with fetal congenital anomalies.
  • Women with absent or reversed diastolic flow in the umbilical artery at the time of recruitment.
  • Women with preeclampsia or on anti-coagulant thereby.
  • Women who refused to participate in our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Advanced Fetal Cair Unit - Assiut University

Asyut, Egypt

Location

MeSH Terms

Conditions

Fetal Hypoxia

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 7, 2017

First Posted

May 10, 2017

Study Start

August 1, 2017

Primary Completion

May 1, 2022

Study Completion

September 1, 2022

Last Updated

November 30, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will share

Locations